<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jikuya R</submitter><funding>U.S. Department of Health and Human Services</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Japan Society for the Promotion of Science</funding><funding>Government of South Australia</funding><pagination>104596</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10200853</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>92</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Birt-Hogg-Dubé (BHD) syndrome, caused by germline alteration of folliculin (FLCN) gene, develops hybrid oncocytic/chromophobe tumour (HOCT) and chromophobe renal cell carcinoma (ChRCC), whereas sporadic ChRCC does not harbor FLCN alteration. To date, molecular characteristics of these similar histological types of tumours have been incompletely elucidated.&lt;h4>Methods&lt;/h4>To elucidate renal tumourigenesis of BHD-associated renal tumours and sporadic renal tumours, we conducted whole genome sequencing (WGS) and RNA-sequencing (RNA-seq) of sixteen BHD-associated renal tumours from nine unrelated BHD patients, twenty-one sporadic ChRCCs and seven sporadic oncocytomas. We then compared somatic mutation profiles with FLCN variants and RNA expression profiles between BHD-associ</pubmed_abstract><journal>EBioMedicine</journal><pubmed_title>Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.</pubmed_title><pmcid>PMC10200853</pmcid><funding_grant_id>18H04049</funding_grant_id><funding_grant_id>21H03068</funding_grant_id><funding_grant_id>HHSN261201500003I</funding_grant_id><funding_grant_id>20K07395</funding_grant_id><funding_grant_id>19K07769</funding_grant_id><funding_grant_id>19K18591</funding_grant_id><funding_grant_id>19K09717</funding_grant_id><funding_grant_id>HHSN261201500003C</funding_grant_id><funding_grant_id>19K16563</funding_grant_id><funding_grant_id>19K09694</funding_grant_id><funding_grant_id>20K18121</funding_grant_id><funding_grant_id>18H02938</funding_grant_id><funding_grant_id>19K23781</funding_grant_id><pubmed_authors>Muraoka K</pubmed_authors><pubmed_authors>Komeya M</pubmed_authors><pubmed_authors>Aomori K</pubmed_authors><pubmed_authors>Ito Y</pubmed_authors><pubmed_authors>Jikuya R</pubmed_authors><pubmed_authors>Kawaura S</pubmed_authors><pubmed_authors>Lee H</pubmed_authors><pubmed_authors>Kanazashi Y</pubmed_authors><pubmed_authors>Fujii S</pubmed_authors><pubmed_authors>Makiyama K</pubmed_authors><pubmed_authors>Hasumi H</pubmed_authors><pubmed_authors>Nakagawa H</pubmed_authors><pubmed_authors>Kato I</pubmed_authors><pubmed_authors>Shuch BM</pubmed_authors><pubmed_authors>Ito H</pubmed_authors><pubmed_authors>Okawa Y</pubmed_authors><pubmed_authors>Iribe Y</pubmed_authors><pubmed_authors>Furuya M</pubmed_authors><pubmed_authors>Hamanoue H</pubmed_authors><pubmed_authors>Song W</pubmed_authors><pubmed_authors>Tamura T</pubmed_authors><pubmed_authors>Imoto S</pubmed_authors><pubmed_authors>Sasagawa S</pubmed_authors><pubmed_authors>Fujita M</pubmed_authors><pubmed_authors>Linehan WM</pubmed_authors><pubmed_authors>Ha K</pubmed_authors><pubmed_authors>Ju YS</pubmed_authors><pubmed_authors>Yao M</pubmed_authors><pubmed_authors>An J</pubmed_authors><pubmed_authors>Schmidt LS</pubmed_authors><pubmed_authors>Mitome T</pubmed_authors><pubmed_authors>Ricketts CJ</pubmed_authors><pubmed_authors>Baba M</pubmed_authors><pubmed_authors>Tatenuma T</pubmed_authors><pubmed_authors>Suda T</pubmed_authors><pubmed_authors>Ohtake S</pubmed_authors><pubmed_authors>Kodama T</pubmed_authors><pubmed_authors>Noguchi G</pubmed_authors><pubmed_authors>Maejima K</pubmed_authors><pubmed_authors>Kim Y</pubmed_authors><pubmed_authors>Johnson TA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.</name><description>&lt;h4>Background&lt;/h4>Birt-Hogg-Dubé (BHD) syndrome, caused by germline alteration of folliculin (FLCN) gene, develops hybrid oncocytic/chromophobe tumour (HOCT) and chromophobe renal cell carcinoma (ChRCC), whereas sporadic ChRCC does not harbor FLCN alteration. To date, molecular characteristics of these similar histological types of tumours have been incompletely elucidated.&lt;h4>Methods&lt;/h4>To elucidate renal tumourigenesis of BHD-associated renal tumours and sporadic renal tumours, we conducted whole genome sequencing (WGS) and RNA-sequencing (RNA-seq) of sixteen BHD-associated renal tumours from nine unrelated BHD patients, twenty-one sporadic ChRCCs and seven sporadic oncocytomas. We then compared somatic mutation profiles with FLCN variants and RNA expression profiles between BHD-associ</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-26T13:02:04.754Z</modification><creation>2025-04-06T14:06:05.41Z</creation></dates><accession>S-EPMC10200853</accession><cross_references><pubmed>37182269</pubmed><doi>10.1016/j.ebiom.2023.104596</doi></cross_references></HashMap>